Skip to Content


Delegation of Authority

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Notice is hereby given that I have delegated to the Commissioner of Food and Drugs the authority under Public Law 107-108 (Best Pharmaceuticals for Children Act), as amended by section 3(b)(2) of Public Law 108-155 (Pediatric Research Equity Act of 2003), to charter, convene, consult, and appoint members to an advisory committee on pediatric therapeutics. This authority may be redelegated.

The October 11, 2002, delegation of authority to you under Public Law 107-108 (Best Pharmaceuticals for Children Act) and Section 222 of the Public Health Service Act, as amended, (42 U.S.C. 217a), is superseded.

This delegation is effective upon date of signature. In addition, I ratified and affirmed any actions taken by you or your subordinates, which involved the exercise of the authorities delegated herein, prior to the effective date of this delegation.

Start Signature

Dated: April 30, 2004.

Tommy G. Thompson,

Secretary, Department of Health and Human Services.

End Signature End Preamble

[FR Doc. 04-10600 Filed 5-10-04; 8:45 am]